We found that paternal use of some of the non-insulin anti-hyperglycemic agents was related to certain adverse outcomes, and we cannot rule out that these associations are caused by diabetes itself, or uncontrolled disease, rather than the drug. The gene discussed is INS; the disease is diabetes mellitus.